1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Accendra Health, Inc.

Accendra Health, Inc.

ACH
Accendra Health, Inc.US flagNew York Stock Exchange
1.08
USD
- -
- -
82.71MMarket Cap
Accendra Health, Inc.
ACH
(New York Stock Exchange)

Recent

price

1.08

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
130.36
137.48
141.29
144.85
151.72
157.33
159.16
155.3
156.93
152.06
133.82
134.52
133.64
33.68
34.92
35.92
34.48
Revenue per Share
1.77
1.84
1.74
1.77
1.06
1.65
1.76
1.21
-7.28
-1.03
0.47
3.05
0.3
-0.54
-4.73
-14.31
-3.94
Basic EPS, GAAP
1.61
0.51
2.86
1.28
-1.2
3.76
2.58
0.1
0.83
1.88
4.42
1.02
2.13
7.42
-0.28
-3.94
-4.76
Free Cash Flow per Basic Share
0.72
0.81
0.89
0.97
1.01
1.02
1.04
1.05
0.8
0.09
0.01
0.01
- -
- -
- -
- -
- -
Dividend per Share
13.52
14.47
15.37
16.23
15.71
15.8
15.73
16.52
8.32
7.35
9.69
12.44
12.4
12.07
7.6
-6.03
-7.16
Book Value per Share
9.23
10.2
10.36
11.22
7.28
7.61
7.58
1.91
-3.37
-3.44
1.02
4.49
-14.89
-14.06
-11.03
-23.9
-24.15
Tangible Book Value per Share
62
63
63
63
62
62
61
60
60
61
63
73
74
76
77
77
77
Basic Weighted Avg Shares
8,124
8,628
8,868
9,072
9,440
9,773
9,723
9,318
9,418
9,211
8,480
9,785
9,955
2,553
2,680
2,762
2,647
Sales/Revenue/Turnover
2.67
2.51
2.33
2.32
2.14
2.34
2.31
1.61
1.28
1.12
2.85
4.52
2.78
8.44
7.39
8.03
5.7
Operating Margin (%)
29
34
40
51
63
66
55
59
102
117
93
91
229
210
181
215
256
Depreciation Expense
111
115
109
111
67
103
109
73
-437
-62
30
222
22
-41
-363
-1,101
-302
Net Income, GAAP
39.11
39.32
40.55
40.06
47.42
40.3
36.95
- -
- -
- -
19.87
19.93
- -
41.66
- -
- -
- -
Effective Tax Rate (%)
1.36
1.34
1.23
1.22
0.7
1.06
1.12
0.78
-4.64
-0.68
0.35
2.26
0.22
-1.62
-13.53
-39.85
-11.41
Profit Margin (%)
709
793
705
736
903
911
927
872
1,067
991
790
978
729
211
169
-399
-395
Working Capital
209
213
215
213
609
568
565
901
1,648
1,625
1,106
1,110
2,698
2,113
1,888
1,870
1,781
LT Debt
858
919
974
1,025
991
993
960
1,015
518
462
712
939
946
924
586
-461
-551
Total Equity
12.55
11.53
10.29
10.17
7.37
8.61
9.25
- -
- -
- -
10.03
18.5
- -
3.65
- -
- -
- -
Return on Invested Capital (%)
11.67
11.23
10.08
9.78
5.36
7.57
8.16
- -
- -
- -
4.95
13.45
- -
0.78
- -
- -
- -
Return on Capital (%)
13.6
12.98
11.53
11.11
6.54
10.33
11.03
7.37
-56.98
-12.72
5.09
26.85
2.38
-4.42
-48.02
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
250
581
- -
LT Borrowings
1,800
1,522
1,718
LT Finance Leases
70
67
63
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
76
77
77
Market Capitalization
214
175
263

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
548
588
271
Cash, Cash Equivalents & STI
282
337
8
Accounts Receivable, Net
96
104
120
Inventories
74
65
73
Total Current Liabilities
947
1,203
666
Payables & Accruals
433
408
395
ST Debt
250
581
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-18.81%
-36.98%
-178.62%
Free Cash Flow
239.42%
304.44%
1,331.81%
Net Income, GAAP
28.72%
249.81%
203.47%
Sales/Revenue/Turnover
-6.29%
-9.83%
3.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,613
660
687
2,696
2,680
2025
674
682
697
709
2,762
2026
628
613
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.29
-0.42
-0.17
-3.84
-4.73
2025
-0.32
-11.3
-1.94
-0.73
-14.31
2026
-0.08
-1.16
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Grand Brilliance Group Holdings Limited (8372.HK)
Patterson Companies, Inc. (PDCO)
Chandra Bhagat Pharma Limited (CBPL.BO)
WeLeader Biomedical Co., Ltd. (7713.TWO)
Sinco Pharmaceuticals Holdings Limited (6833.HK)
Cowealth Medical Holding Co., Ltd. (4745.TWO)
Business
Aluminum Corporation of China Limited Aluminum Corporation of China Limited (Chalco) engages in the production and sale of alumina, primary aluminum, aluminum alloy products, aluminum ores, bauxite, coal, carbon products, fabricated aluminum products, fabricated copper products, rare metals and rare earth; it operates through segments including alumina refining, primary aluminum smelting, energy generation via thermal power and new energy sources, trading, mining of bauxite and other resources, engineering and technical services, international joint ventures, and logistics. Headquartered in Beijing, China, and founded in 2001 as a holding subsidiary of Aluminum Corporation of China (Chinalco), the company maintains primary operations in China with overseas activities in Peru's Toromocho copper mine producing copper, silver, and molybdenum, and participation in Guinea's Simandou iron ore project alongside partners including Rio Tinto. Recent developments include the commissioning of a 400,000-tonne-per-year green aluminum smelter in Yunnan Province powered by hydropower in early 2024 to support decarbonization efforts; plans announced in late 2024 to acquire slab ingot assets from Chinalco High-end Manufacturing; establishment of a joint venture in 2025 with Chinalco, Yunnan Copper, Chihong Zinc & Germanium, registered capital RMB1,500 million; and scheduling of a 2025 extraordinary general meeting to approve connected transactions with Chinalco covering logistics, production supplies, mineral supply, and financial services.

Company News

Company News APIChatGPT

  • defenseworld.net

    BlackRock Inc. Acquires New Stake in Accendra Health, Inc. $ACH

  • businesswire.com

    Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

  • gurufocus.com

    Square Credit Card Levels Up: Rewards Built for Small Businesses and a New Way to Pay Vendors

  • seekingalpha.com

    Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

  • businesswire.com

    Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

  • businesswire.com

    Accendra Health Reports Second Quarter 2026 Financial Results

  • businesswire.com

    Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

  • businesswire.com

    Credova Expands Guidefitter Relationship, Bringing ACH Payments to Marketplace Checkout and the Guidefitter Wallet

  • gurufocus.com

    Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

  • businesswire.com

    Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

  • zacks.com

    Is the Options Market Predicting a Spike in Accendra Health Stock?

  • gurufocus.com

    Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

  • businesswire.com

    Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

  • gurufocus.com

    Accendra Health Announces Early Results of Offers and Consent Solicitations

  • businesswire.com

    Accendra Health Announces Early Results of Offers and Consent Solicitations

  • businesswire.com

    Accendra Health Announces Offers and Consent Solicitations

  • seekingalpha.com

    Accendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks Transcript

  • seekingalpha.com

    Accendra Health Makes Progress Addressing Its Debt Load

  • seekingalpha.com

    Accendra Health, Inc. (ACH) Q1 2026 Earnings Call Transcript

  • businesswire.com

    Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction